Clean Science reported Q4 FY26 standalone EBITDA of ₹88 crore, with margins resilient at 45.6% despite a 19% YoY sales decline.
The Board approved a final dividend of ₹4 per share, implying a total annual payout ratio of 25% for FY2026.
FY26 total capex was ~₹220 crore, primarily invested in the wholly-owned subsidiary Clean Fino Chem Ltd (CFCL).
Executive Directors voluntarily forgone a substantial portion of their performance bonus entitlement for FY2026.